Table of Contents
ISRN Psychiatry
Volume 2012, Article ID 703751, 5 pages
http://dx.doi.org/10.5402/2012/703751
Clinical Study

Evaluation of Efficacy, Safety, and Cognitive Profile of Amisulpride Per Se and Its Comparison with Olanzapine in Newly Diagnosed Schizophrenic Patients in an 8-Week, Double-Blind, Single-Centre, Prospective Clinical Trial

1Department of Pharmacology, MGM Medical College, Indore 452001, India
2Department of Psychiatry, MY Hospital, Indore 452001, India

Received 23 November 2011; Accepted 29 December 2011

Academic Editors: A. Michael and A. Weizman

Copyright © 2012 Ganesh R. Pawar et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

How to Cite this Article

Ganesh R. Pawar, P. Phadnis, and A. Paliwal, “Evaluation of Efficacy, Safety, and Cognitive Profile of Amisulpride Per Se and Its Comparison with Olanzapine in Newly Diagnosed Schizophrenic Patients in an 8-Week, Double-Blind, Single-Centre, Prospective Clinical Trial,” ISRN Psychiatry, vol. 2012, Article ID 703751, 5 pages, 2012. https://doi.org/10.5402/2012/703751.